Middle East Healthcare Company

4009.SRSAUHealthcare● Active

$33.00

+$0.60(+1.85%)

Market Cap$3.0B

P/E Ratio—

52W High$60.7

52W Low$28.66

Avg Volume756K

Open$32.60

Beta-0.05

Free Cash Flow Financials Revenue

Middle East Healthcare Company (4009.SR) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

4009.SR · free cash flow · updated Jun 15, 2026

Core FCF metrics

4009.SR · FCF · TTM · margin & CAGR

Free cash flow was −$99.8M for FY2025 (fiscal year ending 2025-12-31), down 134.8% year-over-year The FCF margin was -3.2%.

FY2025 Free Cash Flow−$99.8M▼ -134.8% YoY

Trailing 12M (TTM)−$117.9Mtrailing 4 quarters sum

FCF Margin-3.2%−$99.8M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

4009.SR · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$355.4M(455M)−$99.8M▼ 134.8%-3.2%

FY2024$766.0M(479M)$286.7M▲ +794.4%9.9%

FY2023$191.1M(232M)−$41.3M▲ +76.2%-1.6%

FY2022$76.0M(250M)−$173.5M▲ +49.1%-8.1%

FY2021$76.6M(418M)−$340.9M▲ +38.9%-18.2%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

4009.SR · P/FCF · FCF yield · FCF per share

Middle East Healthcare Company (4009.SR) reported negative free cash flow of −$0.10B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

4009.SR · cash flow statement · operating / investing / financing

For FY2025, Middle East Healthcare Company generated $355.4M in operating cash flow and spent 455M in capital expenditures, yielding −$99.8M in free cash flow.

Operating Activities

+$355.4M

Cash from core business operations

2025-12-31

Investing Activities

−$338.4M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$39.9M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($355.4M) − |CapEx| (455M) = FCF (−$99.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

4009.SR vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Middle East Healthcare CompanyYOU

4009.SR

−$99.8M-134.8%-3.2%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Middle East Healthcare Company (4009.SR) reported free cash flow of −$99.8M for FY2025 (fiscal year ending 2025-12-31), down 134.8% year-over-year. The FCF margin was -3.2%.

Based on available data, Middle East Healthcare Company has maintained positive free cash flow for at least 5 fiscal year(s). FCF peaked at $286.7M in FY2024.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

4009.SR free cash flow · 8 questions

Middle East Healthcare Company free cash flow was −$99.8M for FY2025, down 134.8% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$117.9M.

4009.SR free cash flow4009.SR FCF4009.SR FCF 20254009.SR free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Middle East Healthcare Company · Middle East Healthcare Company SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026